Matthew Gline insider trades: Roivant Sciences (ROIV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | ROIV | ↓ Sell | 1,740,000 | $21.68 | $37.7M | Direct | Dec 17, 2025 (2d) |
| Sep 18, 2025 | ROIV | ↑ Buy | 3,315 | $15.07 | $50K | Direct | Sep 18, 2025 (0d) |
| Sep 23, 2024 | ROIV | ↓ Sell | 1,983,257 | $11.79 | $23.4M | Direct | Sep 24, 2024 (1d) |
| Oct 25, 2022 | ROIV | ↓ Sell10b5-1 | 19,276 | $4.40 | $85K | Direct | Oct 27, 2022 (2d) |
| Sep 23, 2022 | ROIV | ↓ Sell10b5-1 | 21,053 | $3.07 | $65K | Direct | Sep 27, 2022 (4d) |
| Aug 24, 2022 | ROIV | ↓ Sell10b5-1 | 20,009 | $3.71 | $74K | Direct | Aug 26, 2022 (2d) |
| Jul 25, 2022 | ROIV | ↓ Sell10b5-1 | 20,455 | $4.33 | $89K | Direct | Jul 27, 2022 (2d) |
| Jun 23, 2022 | ROIV | ↓ Sell10b5-1 | 19,855 | $4.34 | $86K | Direct | Jun 27, 2022 (4d) |
| May 20, 2022 | ROIV | ↓ Sell | 139,791 | $3.70 | $517K | Direct | May 24, 2022 (4d) |
| Apr 25, 2022 | ROIV | ↓ Sell10b5-1 | 8,509 | $3.84 | $33K | Direct | Apr 27, 2022 (2d) |
| Mar 30, 2022 | ROIV | ↓ Sell10b5-1 | 33,686 | $4.84 | $163K | Direct | Apr 1, 2022 (2d) |
| Mar 25, 2022 | ROIV | ↓ Sell10b5-1 | 35,386 | $5.06 | $179K | Direct | Mar 29, 2022 (4d) |
| Mar 18, 2022 | ROIV | ↓ Sell10b5-1 | 82,006 | $5.13 | $421K | Direct | Mar 22, 2022 (4d) |
| Mar 7, 2022 | ROIV | ↓ Sell10b5-1 | 92,324 | $5.52 | $510K | Direct | Mar 9, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ROIV insiders
Open-market trades in the last 12 months
About Matthew Gline's insider trades
Matthew Gline is CEO at Roivant Sciences (ROIV). Since Mar 7, 2022, Matthew has reported 1 open-market purchase worth $50K and 13 sales worth $63.3M on SEC Form 4. In the last 12 months: 1 sale ($37.7M).
10 sales (3% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (26 filings), other transactions (18 filings), option exercises (9 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.